Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines
- PMID: 19760794
- PMCID: PMC3292176
- DOI: 10.1002/hed.21198
Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines
Abstract
Background: We established multiple University of Michigan Squamous Cell Carcinoma (UM-SCC) cell lines. With time, these have been distributed to other labs all over the world. Recent scientific discussions have noted the need to confirm the origin and identity of cell lines in grant proposals and journal articles. We genotyped the UM-SCC cell lines in our collection to confirm their unique identity.
Method: Early-passage UM-SCC cell lines were genotyped and photographed.
Results: Thus far, 73 unique head and neck UM-SCC cell lines (from 65 donors, including 21 lines from 17 females) were genotyped. In 7 cases, separate cell lines were established from the same donor.
Conclusions: These results will be posted on the UM Head and Neck SPORE Tissue Core website for other investigators to confirm that the UM-SCC cells used in their laboratories have the correct features. Publications using UM-SCC cell lines should confirm the genotype.
Figures
Similar articles
-
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.Head Neck. 2012 Oct;34(10):1480-91. doi: 10.1002/hed.21962. Epub 2011 Dec 13. Head Neck. 2012. PMID: 22162267 Free PMC article.
-
In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.J Otolaryngol Head Neck Surg. 2016 Apr 26;45:26. doi: 10.1186/s40463-016-0140-8. J Otolaryngol Head Neck Surg. 2016. PMID: 27117272 Free PMC article.
-
Evidence that loss of chromosome 18q is associated with tumor progression.Cancer Res. 1997 Mar 1;57(5):824-7. Cancer Res. 1997. PMID: 9041179
-
Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.Cancer Res. 1999 Jul 15;59(14):3468-74. Cancer Res. 1999. PMID: 10416612
-
Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.Aust N Z J Surg. 2000 Aug;70(8):601-6. doi: 10.1046/j.1440-1622.2000.01910.x. Aust N Z J Surg. 2000. PMID: 10945556 Review.
Cited by
-
Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.Radiat Res. 2016 May;185(5):496-504. doi: 10.1667/RR14093.1. Epub 2016 Apr 29. Radiat Res. 2016. PMID: 27128739 Free PMC article.
-
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.Mol Cancer Ther. 2012 Nov;11(11):2401-9. doi: 10.1158/1535-7163.MCT-12-0448. Epub 2012 Sep 12. Mol Cancer Ther. 2012. PMID: 22973056 Free PMC article.
-
Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.Oral Dis. 2015 Jul;21(5):593-601. doi: 10.1111/odi.12321. Epub 2015 Apr 6. Oral Dis. 2015. PMID: 25662766 Free PMC article.
-
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab.Mol Ther. 2022 Jan 5;30(1):468-484. doi: 10.1016/j.ymthe.2021.06.009. Epub 2021 Jun 8. Mol Ther. 2022. PMID: 34111559 Free PMC article.
-
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.Oncotarget. 2012 Jan;3(1):31-43. doi: 10.18632/oncotarget.430. Oncotarget. 2012. PMID: 22289787 Free PMC article.
References
-
- Lansford C, Grenman R, Bier H, Somers KD, Kim S-Y, Whiteside TL, Clayman GL, Welkoborsky HJ, Carey TE. Head and Neck Cancers. In: Masters JaPB., editor. Human Cell Culture Vol II Cancer Cell Lines Part 2. Norwell MA: Kluwer Academic Publishers; 1999. pp. 185–256.
-
- Grenman R, Carey TE, McClatchey KD, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer. 1991;67(11):2741–7. - PubMed
-
- Bradford CR, Zhu S, Ogawa H, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003;25(8):654–61. - PubMed
-
- Van Dyke DL, Worsham MJ, Benninger MS, et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994;9(3):192–206. - PubMed
-
- Kimmel KA, Carey TE. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res. 1986;46(7):3614–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials